MedTrace Logo

Fecal Microbiota Transplantation (FMT): PRIM-DJ2727

NCT03786900 · Status: AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2026-03-09

No results posted yet for this study

Summary

The Fecal Microbiota Transplantation (FMT) product PRIM-DJ2727 is prepared from human stool from a healthy, screened donor.

Requestors will contact the study team about the product (PRIM-DJ2727) by email, visit, or phone call. A screening list for donors will be provided to make sure that the list fits the requestor's requirements. A basic fee will be requested to recover the cost of making the product. After an agreement is made, a contract will be signed between the 2 parties. A week before the treatment, requestors will contact the study team for possible FMT product delivery. Delivery method will be confirmed for delivery by personnel (within 10 minutes driving distance) or by using FedEx services. Each delivered product will have an approved delivery form signed and dated by both the person who prepared the delivery and the person who received the package.

Conditions

  • Recurrent Clostridium Difficile Infection
  • Multidrug-resistant Klebsiella Pneumoniae Urinary Tract Infection

Interventions

BIOLOGICAL

Fecal Microbiota Transplantation (FMT) product PRIM-DJ2727

Sponsors & Collaborators

  • Herbert DuPont, MD

    lead OTHER

Principal Investigators

  • Herbert DuPont, MD · The University of Texas Health Science Center, Houston

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03786900 on ClinicalTrials.gov